当前位置： SCI文献检索 > BRITISH JOURNAL OF CLINICAL PHARMACOLOGY期刊下所有文献 > Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.

Abstract：

AIMS:To compare the onset and duration of action of the new antihistamine levocetirizine with that of the second-generation antihistamine fexofenadine using the Vienna Challenge Chamber (VCC). The latter is an environment where subjects can be exposed to specific aeroallergens in controlled and reproducible conditions allowing for precise comparisons of anti-allergic drugs. METHODS:Ninety-four subjects received a single dose of levocetirizine 5 mg, fexofenadine 120 mg or placebo in a random order using a three-way cross-over design. On day 1, subjects were exposed to grass pollens (1500 grains/m(3)) in the VCC over a period of 4 h. Treatment was given 2 h after the start of challenge. On day 2, 22 h after drug intake, subjects were again exposed to pollens for 6 h. Specified symptoms were assessed by the subjects every 15 min using 5-point scales. The main efficacy parameter was the change from baseline in the Major Symptom Complex Score (MSCS = sum of rhinorrhea, sneezing, itchy nose and eyes). RESULTS:Baseline characteristics, including symptoms scores, were similar in the three study groups. During the first 2 h after drug intake both antihistamines achieved clinically relevant and significant (P < 0.001) improvements in symptom scores. Twenty-two to 24 h after drug intake, mean (SEM) MSCS reductions were: 1.9 (0.3) after placebo (baseline of 9.7), 3.8 (0.3) after fexofenadine (baseline of 9.9), and 5.1 (0.3) after levocetirizine (baseline of 9.8). Levocetirizine was significantly (P < 0.001) more effective than fexofenadine with a score difference of 1.3 (95% CI 0.7, 1.9). This was maintained until the end of the study (up to 28 h). CONCLUSIONS:A rapid onset of action in alleviating seasonal allergic rhinitis (SAR) symptoms of subjects exposed to grass pollens in the VCC was observed after levocetirizine and fexofenadine. Levocetirizine was more effective than fexofenadine at and later than 22 h after drug intake, an indication of the longer-duration of action of levocetirizine.

journal_name

Br J Clin Pharmacol

journal_title

British journal of clinical pharmacology

authors

Horak F,Zieglmayer PU,Zieglmayer R,Kavina A,Lemell P

doi

10.1111/j.1365-2125.2005.02377.x

keywords:

subject

Has Abstract

pub_date

2005-07-01 00:00:00

pages

24-31

issue

eissn

0306-5251

issn

1365-2125

pii

BCP2377

journal_volume

pub_type

临床试验,杂志文章,随机对照试验

在线工具

Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration.